Article Text
Correction
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Statistics from Altmetric.com
Li W, Wu Y, Li X, et al. Intravenous tirofiban therapy for patients with capsular warning syndrome. Stroke Vasc Neurol 2019. doi: 10.1136/svn-2018-000163. [Epub ahead of print 9 Jan 2019].
In the Results section of the Abstract, “After treatment, in T-group, four patients (26.7%) had recurrent attacks, and NIHSS scores were in 11 patients (73.3%) at 24 hours” should read “After treatment, in T-group, four patients (26.7%) had recurrent attacks, and NIHSS scores were 0 in 11 patients (73.3%) at 24 hours.”